PFE - OPKO Health: A Hero Against The COVID-19 Villain But Has To Control Those Expenses Going Forward
Since the second week of March, BioReference Laboratories, a subsidiary of OPKO Health (OPK), has been running at full speed carrying out PCR tests to detect people who may have been in contact with SARS-CoV-2, the coronavirus causing the COVID-19 pandemic. This is crucial in limiting the spread of infection. Additionally, as of April 27, 2020, OPKO Health started offering COVID-19 antibody testing.
It is easy for investors to be influenced by the positive news, but it is also important to look at the financial side too as COVID-19 has not been just